Advanced search

Mr. Raffi Garabedian is a Co-Chief Technology Officer at First Solar, Inc. He is on the Board of Directors at ESS Tech, Inc., Covalent Metrology Services, Inc. and Heliotrope Technologies, Inc. Mr. Garabedian was previously employed as a Chief Executive Officer by Touchdown Technologies, Inc. and a Vice President-Product Development by Integrated Micromachines, Inc. He received his undergraduate degree from Rensselaer Polytechnic Institute and a graduate degree from the University of California, Davis.

Mr. Charles M.
Garabedian is a Relationship Manager at Beaumont Financial Partners LLC.
He Partners with clients to develop and oversee their financial plans and he also analyzes mutual funds for the firm.
Mr. Garabedian was employed as a Vice President by Fidelity Investments (New York).
He earned a BA in Economics from the University of Massachusetts at Amherst and an MBA from Suffolk University’s Sawyer School of Business.
He holds his FINRA Series 66 securities license, as well as his Certified Fund Specialist (CFS) designation.

Mr. Gregory J.
Garabedian is a Senior Managing Director & Equity Portfolio Manager at Wellington Management Co. LLP.
He joined the firm in 2006 and conducts fundamental analysis on global equity and commodity investments, focusing on the insurance, industrials, capital goods, and agricultural industries.
His research supports the investment decision making for a range of portfolios managed for clients of the firm.
He works in Radnor office.
Prior to joining Wellington Management, Mr. Garabedian worked as an Equity Research Analyst at Gabelli and Company from 2005 up to 2006.
Before that, he worked as a forensic Accountant at PricewaterhouseCoopers from 1997 up to 2003.
He earned his MBA from the University of Pennsylvania Wharton in 2005 and his BS in Accounting from Villanova University in 1997.

John joined KB in 2018 as an investor and Venture Partner in Fund I after a long and storied career in the consulting world.
He has been involved with all aspects of KB’s Fund I since retiring as a Senior Partner at Boston Consulting Group in 2018, where he still serves as a BCG Senior Advisor.
Prior to joining KB, John led BCG’s Financial Services Practice in the Americas through the financial crisis.
He has over 30 years of consulting experience on topics ranging from traditional strategy and organization work to breakout growth and digital innovation across banking, wealth / asset management, retail banking and insurance.
John also developed a growth strategy for a leading professional golf tour that included an in-depth assessment and segmentation of its fan base to drive higher growth and engagement.
He was also part of a major effort to accelerate Chicago’s tech and innovation economy by creating a stronger eco-system across universities, corporate leaders, talent, tech incubators and venture capital.
John also sits on a number of private, public and civic boards, including EVO Payments, Treliant, the Chicago Public Education Fund, Chicago Civic Consulting Alliance, the Illinois Holocaust Museum and Education Center and BCG’s Center of Illinois’ Future.
He received his MBA from the Kellogg Graduate School of Management at Northwestern University and a BS in accounting, magna cum laude, from Frostburg State University.

Suzan Garabedian currently works at Center Stage Associates, Inc. (Maryland), as Trustee.

Christopher Nishan Garabedian is the founder and currently holds the position of Chairman & Chief Executive Officer at Xontogeny LLC, which was founded in 2016.
He is also currently serving as Chairman at Bioharmony Therapeutics, Inc., Forge Biologics, Inc., Massachusetts Biotechnology Council, AsclepiX.
Therapeutics LLC, Zucara Therapeutics, Inc., VivoSense, Inc, Polycore Therapeutics, Inc., and Forge Biologics Holdings LLC.
Additionally, he is a Director at Massachusetts Biotechnology Council, AsclepiX.
Therapeutics LLC, Zucara Therapeutics, Inc., VivoSense, Inc, Polycore Therapeutics, Inc., and Forge Biologics Holdings LLC.
Mr. Garabedian is also a Portfolio Manager at Perceptive Advisors (Private Equity) since 2017.
Previously, he held the positions of President, Chief Executive Officer & Director at Sarepta Therapeutics, Inc. from 2012 to 2015, and Chairman at Landos Biopharma, Inc. from 2021 to 2024.
He has also served as a Director at Vyome Therapeutics, Inc. and Vice President-Corporate Strategy at Celgene Corp.
Mr. Garabedian completed his undergraduate degree at the University of Maryland.

Vicken Garabedian currently works as a Director at Saint Alphonsus Regional Medical Center, Inc.

Eddie Garabedian is currently the Vice President-Marketing at Glu Mobile LLC since 2016.
He completed his undergraduate degree from Santa Clara University.

Mr. Garabedian joined Castanea in 2008 from RBC Capital Markets, where he was an Investment Banking Analyst.
While at RBC, he advised clients on mergers & acquisitions as well as equity and private placement offerings in various industries including Consumer Products, Technology and Energy.
Mr. Garabedian received a BS in Economics, with honors, from the University of Pennsylvania.

Richard S.
Garabedian has worked as a Principal at Luse, Gorman, Pomerenk & Schick PC since 2004.

Alex Garabedian is currently an Associate at Kreos Capital Management (UK) Ltd.
He completed his undergraduate degree at DePaul University.

Amy Garabedian is currently the Secretary & General Counsel at LAVA Therapeutics NV since 2021.
Prior to this, she worked as an Attorney at Ballard Spahr LLP.
From 2015 to 2020, she worked as an Associate General Counsel at Spark Therapeutics, Inc. Ms. Garabedian has a graduate degree from Temple University (Pennsylvania) and Widener University Delaware Law School, and an undergraduate degree from The Pennsylvania State University.

Christopher Garabedian has held director positions at CereVasc, Inc. and Quellis Biosciences LLC.

Raffi Ghazarian worked as a Research Assistant at Scotia Capital, Inc. from 2006 to 2014.
He obtained an undergraduate degree from the University of Toronto in 2005.

Mr. Raffi Killian is Vice President at Heitman Real Estate Securities LLC.
Prior to joining Heitman, Mr. Killian worked for Deloitte & Touche in the real estate valuation group.
Mr. Killian received BS in Civil Engineering from the University of Illinois at Champaign-Urbana and MBA from the Olin School of Business at Washington University in St. Louis.

Raffi Bhardwaj worked as an Associate Analyst at UBS Securities LLC from 2015 to 2018.
He obtained an undergraduate degree from The GW School of Business.

Raffi Babikian is an Independent Director at Laramide Resources Ltd.
He previously served as an Independent Director at Cypherpunk Holdings, Inc., Fission Uranium Corp., and Khan Resources, Inc. He also worked as a Finance Director at Innovotive, Inc. from 2019 to 2021 and as a Vice-President-Investment Banking at DWM Securities, Inc. Mr. Babikian holds an undergraduate degree from McGill University, a graduate degree from Massachusetts Institute of Technology, and an MBA from College des Ingenieurs.

Raffi Basmadjian has worked as a Director at Orange Business Services Participations SA since 2009.

Raffi Elmajian is currently working as the Manager of Corporate Communications at Blue Star Gold Corp.
and as the Head of Corporate Communications at Capitan Silver Corp.
He previously worked as the Head of Corporate Communications at Riverside Resources, Inc. from 2017 to 2022.

Raffi Loussararian worked as Vice President-Finance & Controller at LegalZoom.com, Inc. from 2006 to 2008, as well as at Viva Group LLC from 2005 to 2006.
He also served as VP-Finance, Chief Financial & Accounting Officer at Barfresh Food Group, Inc. from 2019 to 2021.
Loussararian obtained an undergraduate degree from California State University-Northridge.

Raffi Afeyan is the founder.
He founded Ampersand Biomedicines, Inc. in 2000, where he currently holds the title of Chief Innovation Officer.
He is also currently working as a Senior Principal at Flagship Pioneering since 2021.
In his former positions, he served as Vice President at Cellarity Inc. and Generate Biomedicines, Inc. Mr. Afeyan has a graduate degree from Boston University and an undergraduate degree from McGill University.

Boyajian Raffi is currently working as a Principal at Cigna Ventures LLC since 2022.
He completed his undergraduate degree from Michigan State University in 2007.
He then pursued his graduate degree in law from Michigan State University College of Law in 2011.
In the same year, he also completed his MBA from Eli Broad College of Business.

Dan Raffi is currently the Director of Commercial Operations at Guerbet SA, a position he has held since 2023.
Prior to this, he worked as the Chief Operating Officer at Sim&Cure SA.

Raffi Asadorian is currently the Director at Willow Biosciences, Inc. since 2023 and the Chief Financial & Accounting Officer at Talphera, Inc. since 2017.
Previously, he worked as a Partner-Transaction Services at PricewaterhouseCoopers LLP from 1991 to 2007, Chief Financial Officer at Amyris, Inc. from 2015 to 2017, Chief Financial Officer & Senior Vice President at PLIVA dd from 2007 to 2009, Chief Financial Officer at Unilabs SA from 2009 to 2014, and Chief Financial Officer at Barr Pharmaceuticals, Inc. from 2007 to 2009.
Mr. Asadorian obtained an undergraduate degree from Xavier University and an MBA from Manchester Metropolitan University.

Raffi Kamber is currently a Director at Clustree SAS.
Prior to this, he worked as an Investment Director at Alven Capital Partners SA from 2011 to 2020.
He also worked as an Associate at Gimv Information & Communication Technology ICT from 2009 to 2011.
Additionally, he was a Director at Tinyclues SAS.
Mr. Kamber holds an MBA from INSEAD.

Raffi joined LGP as an Associate in 2017.
Prior to joining LGP, Raffi worked as an analyst at Moelis & Company in the Mergers & Acquisitions and Restructuring Groups in Los Angeles.
Raffi graduated with high distinction from the Haas School of Business at the University of California, Berkeley, where he earned a Bachelor of Science degree in Business Administration.

Raffi Adlan has founded the Youth Movement Against Alzheimer's in 2012 and currently holds the title of Member-Advisory Board.

Raffi Sethian worked as COO, EVP & Head-Investor Relations at TerraVest Income Fund from 2010 to 2011.
He also worked as Chief Operating Officer at TerraVest Industries, Inc.

Raffi Mardirosian is the founder of Sedi SAS (2013), IDEAS, Inc. (2008), BlackBox Biometrics, Inc. (2011), and Izuba Energy (2016).
He is currently a Partner at Clean Energy Venture Group LLC, Vice President at Sublime Systems, Inc. (Massachusetts), and Managing Member at Cambridge Creative Development.
Mr. Mardirosian's former jobs include Investment Banking Associate at BNP Paribas Asset Management, Inc. (2009), Consulting Analyst at Renova Capital Partners LLC (2010-2011), Business Analyst at McKinsey & Co., Inc. (2010-2012), Principal at Flagship Pioneering (2015-2016), Vice President at Joule Unlimited Technologies, Inc. (2015-2017), President at Midori USA, Inc., Analyst at Adn Capital Ventures, Inc. (2008-2010), Business Development Manager at Axcella Health, Inc. (2012-2013), Vice President at Ouster, Inc. (2017-2020), and Associate at 2seeds Network, Inc. (2010).
Mr. Mardirosian obtained an undergraduate degree from Stanford University.